{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:33:12Z","timestamp":1772749992412,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1053\/shem.2002.35986","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:34:06Z","timestamp":1031157246000},"page":"36-38","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies"],"prefix":"10.1053","volume":"39","author":[{"given":"Hagop M","family":"Kantarjian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/shem.2002.35986_BIB1","author":"Cortes"},{"key":"10.1053\/shem.2002.35986_BIB2","author":"Hoover"},{"issue":"suppl 1","key":"10.1053\/shem.2002.35986_BIB3","first-page":"727a","article-title":"R115777, a farnesyl transferase inhibitor (FTI), has significant anti-leukemia activity in patients with chronic myeloid leukemia (CML)","volume":"98","author":"Thomas","year":"2001","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/shem.2002.35986_BIB4","first-page":"623a","article-title":"Phase I study of farnesyl transferase inhibitor, R115777, in patients with myelodysplastic syndrome","volume":"98","author":"Kurzrock","year":"2001","journal-title":"Blood"},{"key":"10.1053\/shem.2002.35986_BIB5","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1182\/blood.V97.11.3361","article-title":"Clinical and biological activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: A phase I clinical-laboratory correlative trial","volume":"97","author":"Karp","year":"2001","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1053\/shem.2002.35986_BIB6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/shem.2002.35985","article-title":"Farnesyltransferase inhibitors and myeloid malignancies: Phase I evidence of Zarnestra activity in high-risk leukemias","volume":"39","author":"Lancet","year":"2002","journal-title":"Semin Hematol"},{"issue":"suppl 1","key":"10.1053\/shem.2002.35986_BIB7","first-page":"848a","article-title":"Phase II study of R115777, a farnesyltransferase inhibitor, in myelodysplastic syndrome","volume":"98","author":"Kurzrock","year":"2001","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196302500597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196302500597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T11:22:51Z","timestamp":1554895371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196302500597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0037196302500597"],"URL":"https:\/\/doi.org\/10.1053\/shem.2002.35986","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}